The poison pill is a standard NOL preservation tool and does not signal an imminent takeover threat. Monitor for any Schedule 13D filings that would indicate a shareholder approaching the 4.9% threshold, which would activate the pill and create a potential trading catalyst.
Price Chart
Executive Summary
Accendra Health adopted a Section 382 Rights Agreement (poison pill) to preserve its net operating losses (NOLs) and other tax attributes by deterring any person or group from acquiring 4.9% or more of outstanding common stock. The plan triggers if an ownership change under Section 382 of the Internal Revenue Code occurs, allowing other holders to acquire shares at a 50% discount. This is a routine defensive measure for NOL preservation, filed one day after the CEO's retirement announcement, suggesting the board is proactively protecting tax assets during a leadership transition.
Key Facts
- Board adopted a Section 382 Rights Agreement (Tax Asset Preservation Plan) dated August 10, 2026.
- Plan triggers if a person or group acquires beneficial ownership of 4.9% or more of outstanding common stock.
- Upon an ownership change, non-triggering holders can acquire common shares at a 50% discount to the market price.
- Plan expires on August 10, 2029, unless terminated earlier by the Board.
- 100,000 shares of Series C Cumulative Preferred Stock authorized for the plan.
- Filed one day after CEO Ed Pesicka's retirement announcement (August 9, 2026).
Financial Impact
No financial impact; the plan is a defensive measure with no immediate cash or dilution effect.
Risk Factors
- If a shareholder inadvertently crosses the 4.9% threshold, the pill could trigger severe dilution and litigation.
- The plan may deter potential acquirers, limiting takeover premium for shareholders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-093381 |
| Document: tm2622667d3_8k.htm | 0001104659-26-093381 |
| Document: tm2622667d3_ex3-1.htm | 0001104659-26-093381 |
| Document: tm2622667d3_ex99-1.htm | 0001104659-26-093381 |
| Document: 0001104659-26-093381-index-headers.html | 0001104659-26-093381 |
| Document: 0001104659-26-093381-index.html | 0001104659-26-093381 |
| Document: 0001104659-26-093381.txt | 0001104659-26-093381 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $0.3905 $0.2202 | ▲ +43.61% | ▲ +42.12% | $0.2029 (+48.04%) |
Oct 7, 2026 19d ago | SC 13G | $0.4729 $0.3128 | ▼ −33.85% | ▼ −32.87% | $0.2029 (−57.09%) |
Sep 17, 2026 5w ago | 8-K | $1.03 $0.7332 | ▼ −28.82% | ▼ −29.42% | $0.2029 (−80.30%) |
Aug 17, 2026 10w ago | 8-K | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2029 (−81.04%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2029 (−81.04%) |
Aug 10, 2026 11w ago | 8-K | $1.26 $1.13 | ▼ −10.32% | ▼ −9.91% | $0.2029 (−83.90%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▲ +23.57% | ▲ +23.52% | $0.2029 (+85.51%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▼ −23.57% | ▼ −23.52% | $0.2029 (−85.51%) |
Jul 27, 2026 13w ago | EFFECT | $3.22 $3.41 | ▲ +5.90% | ▲ +3.39% | $0.2029 (−93.70%) |
Jun 25, 2026 17w ago | 8-K | $3.34 $3.59 | ▲ +7.49% | ▲ +5.32% | $0.2029 (−93.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers